Psychedelic therapy as a complementary treatment approach for alcohol use disorders Read More > May 30, 2018
Ayahuasca and Its DMT- and β-carbolines – Containing Ingredients Block the Expression of Ethanol-Induced Conditioned Place Preference in Mice: Role of the Treatment Environment Read More > May 29, 2018
Ketamine and rapid-acting antidepressants: a new era in the battle against depression and suicide Read More > May 24, 2018
3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial. Read More > May 1, 2018
The epidemiology of 5-methoxy- N,N-dimethyltryptamine (5-MeO-DMT) use: Benefits, consequences, patterns of use, subjective effects, and reasons for consumption Read More > April 30, 2018
Assessment of Alcohol and Tobacco Use Disorders Among Religious Users of Ayahuasca. Read More > April 24, 2018
Ketamine Effects on EEG during Therapy of Treatment-Resistant Generalized Anxiety and Social Anxiety Read More > April 24, 2018
Effects of N, N-Dimethyltryptamine on Rat Behaviors Relevant to Anxiety and Depression Read More > April 24, 2018
Indolethylamine-N-methyltransferase Polymorphisms: Genetic and Biochemical Approaches for Study of Endogenous N,N,-dimethyltryptamine Read More > April 23, 2018
